<a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new">📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.</a>Dr. Komal Patil-Sisodia records live from her hotel room on the final night of the ADA 86th Annual Scientific Sessions in New Orleans — still processing what she witnessed earlier that week. The NIH director didn&apos;t show up to his own keynote. A substitute speaker framed diabetes research under the MAHA agenda. And five physicians were escorted out of the conference by security for handing out a peer-reviewed article published in the ADA&apos;s own journal.This episode is her unfiltered account of what happened, what the science actually says, and why none of us — patients, clinicians, or researchers — can afford to let it quietly recede.In this episode:<ul><li>What the Kahn et al. Diabetes Care editorial actually argues</li><li>Why an 89% drop in NIH funding notices is more alarming than it sounds</li><li>How a new policy is draining the research pipeline without a single congressional vote</li><li>The landmark diabetes trials — DPP, DCCT, TrialNet — that exist because of the infrastructure now being gutted</li><li>A frank assessment of the ADA&apos;s official statement</li><li>Why diverse, long-horizon NIH research is existential for underserved populations</li><li>Concrete actions for patients, clinicians, researchers, and the community</li></ul>Timestamps:00:00 Welcome to Clearly Hormonal 01:03 Why This Episode Now 01:38 My Diabetes Roots 02:32 Keynote Cancellation Shock 03:46 Editorial Handout Incident 04:59 Inside the Kahn Editorial 06:13 Funding Collapse Explained 07:57 Oversight Councils Undermined 09:02 Policy Loophole Chokes Grants 10:24 Why NIH Research Matters 11:40 Why I Stayed 13:44 What the Keynote Said 15:35 The Core Contradiction 17:49 ADA Statement Breakdown 21:22 Who Gets Hurt Most 23:55 What We Can Do Next 25:56 Closing and ResourcesResources mentioned:<ul><li><a href='https://diabetesjournals.org/care/article/49/6/901/164764/Misguided-Brushes-of-a-Pen-Continue-to-Dismantle'>Kahn et al. Diabetes Care editorial (2026)</a></li><li><a href='https://diabetes.org/advocacy/advocacy-library'>ADA contact and advocacy tools</a></li><li><a href='https://www.congress.gov/members/find-your-member'>Congressional representative lookup</a></li><li><a href='https://www.house.gov/representatives/find-your-representative'>House of Representatives lookup</a></li><li><a href='https://www.statnews.com/2026/06/05/ada-conference-new-orleans-richard-woychik-synergy-nih-maha/'>STAT News coverage of the conference</a></li></ul>Find Dr. Patil-Sisodia:<ul><li><a href='https://www.instagram.com/drpatilsisodia/'>Instagram</a> &amp; <a href='https://www.tiktok.com/@drpatilsisodia'>TikTok</a>: @drpatilsisodia</li><li><a href='https://eastsidemm.com'>Eastside Menopause &amp; Metabolism</a></li></ul>Clearly Hormonal is for educational purposes only and does not constitute personalized medical advice. Please discuss your individual health concerns with your own healthcare provider.Thanks for listening. Find more info about Clearly Hormonal on the <a href='https://eastsidemm.com/podcast'>website</a> or <a href='https://www.instagram.com/clearlyhormonal'>Instagram</a>.

<description>&lt;p&gt;&lt;a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new"&gt;📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Dr. Komal Patil-Sisodia records live from her hotel room on the final night of the ADA 86th Annual Scientific Sessions in New Orleans — still processing what she witnessed earlier that week. The NIH director didn&amp;apos;t show up to his own keynote. A substitute speaker framed diabetes research under the MAHA agenda. And five physicians were escorted out of the conference by security for handing out a peer-reviewed article published in the ADA&amp;apos;s own journal.&lt;/p&gt;&lt;p&gt;This episode is her unfiltered account of what happened, what the science actually says, and why none of us — patients, clinicians, or researchers — can afford to let it quietly recede.&lt;/p&gt;&lt;p&gt;&lt;b&gt;In this episode:&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;What the Kahn et al. &lt;em&gt;Diabetes Care&lt;/em&gt; editorial actually argues&lt;/li&gt;&lt;li&gt;Why an 89% drop in NIH funding notices is more alarming than it sounds&lt;/li&gt;&lt;li&gt;How a new policy is draining the research pipeline without a single congressional vote&lt;/li&gt;&lt;li&gt;The landmark diabetes trials — DPP, DCCT, TrialNet — that exist because of the infrastructure now being gutted&lt;/li&gt;&lt;li&gt;A frank assessment of the ADA&amp;apos;s official statement&lt;/li&gt;&lt;li&gt;Why diverse, long-horizon NIH research is existential for underserved populations&lt;/li&gt;&lt;li&gt;Concrete actions for patients, clinicians, researchers, and the community&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Timestamps:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;00:00 Welcome to Clearly Hormonal&lt;br/&gt;01:03 Why This Episode Now&lt;br/&gt;01:38 My Diabetes Roots&lt;br/&gt;02:32 Keynote Cancellation Shock&lt;br/&gt;03:46 Editorial Handout Incident&lt;br/&gt;04:59 Inside the Kahn Editorial&lt;br/&gt;06:13 Funding Collapse Explained&lt;br/&gt;07:57 Oversight Councils Undermined&lt;br/&gt;09:02 Policy Loophole Chokes Grants&lt;br/&gt;10:24 Why NIH Research Matters&lt;br/&gt;11:40 Why I Stayed&lt;br/&gt;13:44 What the Keynote Said&lt;br/&gt;15:35 The Core Contradiction&lt;br/&gt;17:49 ADA Statement Breakdown&lt;br/&gt;21:22 Who Gets Hurt Most&lt;br/&gt;23:55 What We Can Do Next&lt;br/&gt;25:56 Closing and Resources&lt;/p&gt;&lt;p&gt;&lt;b&gt;Resources mentioned:&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a href='https://diabetesjournals.org/care/article/49/6/901/164764/Misguided-Brushes-of-a-Pen-Continue-to-Dismantle'&gt;Kahn et al. &lt;em&gt;Diabetes Care&lt;/em&gt; editorial (2026)&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href='https://diabetes.org/advocacy/advocacy-library'&gt;ADA contact and advocacy tools&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href='https://www.congress.gov/members/find-your-member'&gt;Congressional representative lookup&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href='https://www.house.gov/representatives/find-your-representative'&gt;House of Representatives lookup&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href='https://www.statnews.com/2026/06/05/ada-conference-new-orleans-richard-woychik-synergy-nih-maha/'&gt;STAT News coverage of the conference&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Find Dr. Patil-Sisodia:&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a href='https://www.instagram.com/drpatilsisodia/'&gt;Instagram&lt;/a&gt; &amp;amp; &lt;a href='https://www.tiktok.com/@drpatilsisodia'&gt;TikTok&lt;/a&gt;: @drpatilsisodia&lt;/li&gt;&lt;li&gt;&lt;a href='https://eastsidemm.com'&gt;Eastside Menopause &amp;amp; Metabolism&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;em&gt;Clearly Hormonal is for educational purposes only and does not constitute personalized medical advice. Please discuss your individual health concerns with your own healthcare provider.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;Thanks for listening. Find more info about Clearly Hormonal on the &lt;a href='https://eastsidemm.com/podcast'&gt;website&lt;/a&gt; or &lt;a href='https://www.instagram.com/clearlyhormonal'&gt;Instagram&lt;/a&gt;.&lt;/p&gt;</description>

📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply.  Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Dr. Komal Patil-Sisodia records live from her hotel room on the final night of the ADA 86th Annual Scientific Sessions in New Orleans — still processing what she witnessed earlier that week. The NIH director didn't show up to his own keynote. A substitute speaker framed ...

When the Room Goes Quiet: Scientific Integrity, Political Pressure, & What Was Lost at the ADA Conference

<a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new">📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.</a>On May 12, 2026, The Lancet published the results of a 14-year global effort: Polycystic Ovarian Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). For over 170 million women worldwide — most of whom have never received a correct diagnosis — this is not just a nomenclature update. It is a reckoning.In this episode, Dr. Komal Patil-Sisodia breaks down what changed, what didn’t, and why the new name carries profound clinical implications across every hormonal era: adolescence, the reproductive years, perimenopause, and menopause and beyond. She connects the renaming to the 2026 ACC/AHA dyslipidemia guidelines, the 70% undiagnosis rate, and the lifelong metabolic consequences that the old name made invisible.If you’ve ever been handed a birth control pill without a workup, told your symptoms were stress, or felt dismissed in a clinical setting — this episode is for you.Timestamps00:00  Welcome to Clearly Hormonal  —  Dr. Patil-Sisodia introduces the podcast and her clinical background across endocrinology, internal medicine, obesity medicine, and menopause care.01:08  PCOS Gets Renamed  —  The official May 12, 2026 announcement in The Lancet: PCOS is now Polyendocrine Metabolic Ovarian Syndrome (PMOS). Why one letter — C to M — changes everything.02:38  Why the Old Name Hurt  —  The 14-year global process led by Professor Helena Teede involving 56 organizations and 22,000+ survey responses. How the word “polycystic” misdirected care for generations and contributed to delayed diagnosis, stigma, and fragmented treatment.04:32  Breaking Down PMOS  —  Word-by-word analysis: Polyendocrine (system-level hormonal disruption), Metabolic (insulin resistance, cardiovascular risk as core features, not side effects), Ovarian dysfunction (still present, but no longer the whole story).05:48  What Did Not Change  —  The Rotterdam diagnostic criteria remain intact. If you were diagnosed with PCOS, you have PMOS. Your clinical picture is valid. What changed is the language — and what that language demands of clinicians.07:19  Adolescence — The Era of Missed Beginnings  —  How PMOS manifests in teenage girls, why it gets dismissed as normal puberty, and what’s at stake when early insulin resistance goes untreated. The window to act — and how the new name changes what clinicians look for.10:37  Reproductive Years — The Era of Diagnosis and Distraction  —  Why PMOS is most often diagnosed in fertility contexts, and why that misses the metabolic picture. The connection to gestational diabetes, preeclampsia risk, and the 2026 ACC/AHA dyslipidemia guidelines.13:58  Perimenopause — The Era That Intensifies  —  How declining ovarian function accelerates metabolic dysfunction in women with PMOS. Why symptoms quiet in the 30s and return louder in the 40s. The urgent research questions the new name demands.17:16  Menopause and Beyond — The Era the Name Change Protects  —  Why post-menopausal women with PCOS/PMOS history face the highest cardiovascular risk of their lives — and why no one is connecting the dots. Lp(a), ApoB, and what to ask your clinician today.19:09  What the Name Actually Changes  —  A clinical summary: how each word in PMOS shifts the posture of care at every hormonal era. One name. Four eras. A completely different approach.20:56  Takeaways and Call to Action  —  What to do if you have a PMOS diagnosis, what to ask your clinician if you’re post-menopausal, and a message to clinicians: the name changed. Now the care has to change with it.What We Cover<ul><li>The official renaming of PCOS to PMOS (Polyendocrine Metabolic Ovarian Syndrome) in The Lancet, May 2026</li><li>Why the word “polycystic” was scientifically inaccurate and caused measurable clinical harm</li><li>What each word in PMOS actually means clinically</li><li>Why 70% of people with this condition remain undiagnosed — and how framing drives that number</li><li>Era-by-era breakdown: adolescence, reproductive years, perimenopause, menopause and beyond</li><li>The 2026 ACC/AHA dyslipidemia guideline connection: PMOS as a cardiovascular risk enhancer</li><li>Lp(a) and ApoB: why Class 1 universal screening now matters for your PMOS history</li><li>What to ask your clinician at every stage</li></ul>Resources Mentioned<ul><li>The Lancet PMOS Renaming Paper — May 12, 2026</li><li>Professor Helena Teede, Monash University — lead researcher</li><li>Rotterdam Diagnostic Criteria for PMOS</li><li>2026 ACC/AHA Dyslipidemia Guideline (PREVENT equations, Lp(a) universal screening, ApoB targets)</li><li>The Endocrine Society — one of 56 organizations in the renaming process</li></ul>Connect<ul><li>Instagram: @drpatilsisodia</li><li>Podcast: Clearly Hormonal</li><li>Practice: eastsidemm.com</li><li>If this episode resonated, share it with a woman in your life who’s been searching for answers. Leave a review so more women can find this podcast.</li></ul>Thanks for listening. Find more info about Clearly Hormonal on the <a href='https://eastsidemm.com/podcast'>website</a> or <a href='https://www.instagram.com/clearlyhormonal'>Instagram</a>.

<description>&lt;p&gt;&lt;a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new"&gt;📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;On May 12, 2026, The Lancet published the results of a 14-year global effort: Polycystic Ovarian Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). For over 170 million women worldwide — most of whom have never received a correct diagnosis — this is not just a nomenclature update. It is a reckoning.&lt;/p&gt;&lt;p&gt;In this episode, Dr. Komal Patil-Sisodia breaks down what changed, what didn’t, and why the new name carries profound clinical implications across every hormonal era: adolescence, the reproductive years, perimenopause, and menopause and beyond. She connects the renaming to the 2026 ACC/AHA dyslipidemia guidelines, the 70% undiagnosis rate, and the lifelong metabolic consequences that the old name made invisible.&lt;/p&gt;&lt;p&gt;If you’ve ever been handed a birth control pill without a workup, told your symptoms were stress, or felt dismissed in a clinical setting — this episode is for you.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Timestamps&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;00:00  Welcome to Clearly Hormonal  —  Dr. Patil-Sisodia introduces the podcast and her clinical background across endocrinology, internal medicine, obesity medicine, and menopause care.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;01:08  PCOS Gets Renamed  —  The official May 12, 2026 announcement in The Lancet: PCOS is now Polyendocrine Metabolic Ovarian Syndrome (PMOS). Why one letter — C to M — changes everything.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;02:38  Why the Old Name Hurt  —  The 14-year global process led by Professor Helena Teede involving 56 organizations and 22,000+ survey responses. How the word “polycystic” misdirected care for generations and contributed to delayed diagnosis, stigma, and fragmented treatment.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;04:32  Breaking Down PMOS  —  Word-by-word analysis: Polyendocrine (system-level hormonal disruption), Metabolic (insulin resistance, cardiovascular risk as core features, not side effects), Ovarian dysfunction (still present, but no longer the whole story).&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;05:48  What Did Not Change  —  The Rotterdam diagnostic criteria remain intact. If you were diagnosed with PCOS, you have PMOS. Your clinical picture is valid. What changed is the language — and what that language demands of clinicians.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;07:19  Adolescence — The Era of Missed Beginnings  —  How PMOS manifests in teenage girls, why it gets dismissed as normal puberty, and what’s at stake when early insulin resistance goes untreated. The window to act — and how the new name changes what clinicians look for.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;10:37  Reproductive Years — The Era of Diagnosis and Distraction  —  Why PMOS is most often diagnosed in fertility contexts, and why that misses the metabolic picture. The connection to gestational diabetes, preeclampsia risk, and the 2026 ACC/AHA dyslipidemia guidelines.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;13:58  Perimenopause — The Era That Intensifies  —  How declining ovarian function accelerates metabolic dysfunction in women with PMOS. Why symptoms quiet in the 30s and return louder in the 40s. The urgent research questions the new name demands.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;17:16  Menopause and Beyond — The Era the Name Change Protects  —  Why post-menopausal women with PCOS/PMOS history face the highest cardiovascular risk of their lives — and why no one is connecting the dots. Lp(a), ApoB, and what to ask your clinician today.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;19:09  What the Name Actually Changes  —  A clinical summary: how each word in PMOS shifts the posture of care at every hormonal era. One name. Four eras. A completely different approach.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;20:56  Takeaways and Call to Action  —  What to do if you have a PMOS diagnosis, what to ask your clinician if you’re post-menopausal, and a message to clinicians: the name changed. Now the care has to change with it.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;What We Cover&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;The official renaming of PCOS to PMOS (Polyendocrine Metabolic Ovarian Syndrome) in The Lancet, May 2026&lt;/li&gt;&lt;li&gt;Why the word “polycystic” was scientifically inaccurate and caused measurable clinical harm&lt;/li&gt;&lt;li&gt;What each word in PMOS actually means clinically&lt;/li&gt;&lt;li&gt;Why 70% of people with this condition remain undiagnosed — and how framing drives that number&lt;/li&gt;&lt;li&gt;Era-by-era breakdown: adolescence, reproductive years, perimenopause, menopause and beyond&lt;/li&gt;&lt;li&gt;The 2026 ACC/AHA dyslipidemia guideline connection: PMOS as a cardiovascular risk enhancer&lt;/li&gt;&lt;li&gt;Lp(a) and ApoB: why Class 1 universal screening now matters for your PMOS history&lt;/li&gt;&lt;li&gt;What to ask your clinician at every stage&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Resources Mentioned&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;The Lancet PMOS Renaming Paper — May 12, 2026&lt;/li&gt;&lt;li&gt;Professor Helena Teede, Monash University — lead researcher&lt;/li&gt;&lt;li&gt;Rotterdam Diagnostic Criteria for PMOS&lt;/li&gt;&lt;li&gt;2026 ACC/AHA Dyslipidemia Guideline (PREVENT equations, Lp(a) universal screening, ApoB targets)&lt;/li&gt;&lt;li&gt;The Endocrine Society — one of 56 organizations in the renaming process&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Connect&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Instagram: @drpatilsisodia&lt;/li&gt;&lt;li&gt;Podcast: Clearly Hormonal&lt;/li&gt;&lt;li&gt;Practice: eastsidemm.com&lt;/li&gt;&lt;li&gt;If this episode resonated, share it with a woman in your life who’s been searching for answers. Leave a review so more women can find this podcast.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Thanks for listening. Find more info about Clearly Hormonal on the &lt;a href='https://eastsidemm.com/podcast'&gt;website&lt;/a&gt; or &lt;a href='https://www.instagram.com/clearlyhormonal'&gt;Instagram&lt;/a&gt;.&lt;/p&gt;</description>

📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply.  Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. On May 12, 2026, The Lancet published the results of a 14-year global effort: Polycystic Ovarian Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). For over 170 million women worldwide — most of whom have never received a correct...

PCOS is Now PMOS: What the Name Change Means for Every Era of Your Hormonal Life

<a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new">📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.</a>The number-one cause of death in women is still heart disease — and perimenopause is where your cardiovascular risk starts to quietly climb. This week, Dr. Komal sits down with Dr. Harpreet Tsui, an internist, obesity medicine specialist, and founder of Coronado Health (a direct primary care practice in Nevada), to break down the 2026 ACC/AHA Dyslipidemia Guidelines — the biggest update to cholesterol guidelines in years.This is a personal episode. Both physicians are Southeast Asian women with significant family histories of heart disease. Both are managing their own cardiometabolic health in real time. And neither of them is willing to accept &quot;your numbers look fine&quot; as the end of the conversation.They cover what&apos;s changed in the guidelines, which genetic cholesterol markers your doctor may not be ordering, why perimenopause can flip your lipid panel overnight, and the exact language to use at your next appointment to get the full picture. GuestDr. Harpreet Tsui, MD Internist | Obesity Medicine Specialist | Founder, Coronado Health (Direct Primary Care, Henderson, NV)📍 coronadohealthdpc.com 📱 Instagram &amp; TikTok: @drharpreet.tsui Timestamps[0:00] — Podcast intro and medical disclaimer[1:03] — Meet Dr. Harpreet Tsui: internist, obesity medicine specialist, founder of Coronado Health in Nevada — and why both she and Dr. Komal wanted to have this conversation as Southeast Asian women with significant family histories of heart disease[2:48] — Why direct primary care: Dr. Tsui on leaving the 15-minute appointment model to build a practice centered on women&apos;s health, obesity medicine, and actually having enough time to talk[4:42] — Guidelines confusion and statins: from the clear LDL targets of residency training to the ambiguous &quot;lower it if you feel like it&quot; era — and why statins have gotten an unfair reputation despite data showing they reduce heart disease, stroke risk, and even drive plaque regression[7:01] — Mistrust and culture around medications: immigrant family attitudes toward asking for help, the &quot;I can do it on my own&quot; mentality, and how even physicians absorb enough noise to hesitate — including Dr. Tsui, who prescribed herself a statin and left it on her nightstand for two weeks before she could take it[12:14] — Key update: risk-based treatment replaces number-chasing. The new PREVENT ASCVD calculator factors in HDL, triglycerides, family history, ethnicity, and even zip code — and gives you both a 10-year and 30-year cardiovascular risk estimate, not just a snapshot of today[16:11] — Perimenopause and lipid shifts: why cholesterol can change dramatically when estrogen drops, even when lifestyle hasn&apos;t. Dr. Tsui&apos;s LDL went from 77 to 177 in perimenopause. Dr. Komal&apos;s Lp(a) was normal before — and then it wasn&apos;t. Neither of them did anything differently.[20:59] — ApoB and Lp(a) explained: the two genetic cholesterol markers now in the 2026 guidelines as independent cardiac risk factors. Your standard lipid panel can look stone-cold normal while these are quietly elevated — and why both physicians now check them routinely on midlife women[23:28] — Female-specific risk factors are finally in the guidelines: menopause, PCOS, gestational diabetes, and preeclampsia are now formally recognized as independent cardiovascular risk factors. The gestational diabetes gap — including the postpartum glucose tolerance test that routinely gets missed — and why preeclampsia has lifelong cardiovascular implications[29:32] — Lower LDL targets and the case for being more aggressive: below 70 for high-risk patients, below 55 for very high-risk — and why vascular specialists have been pushing for LDL at or below 50 for years ahead of these guidelines[31:33] — Beyond statins: PCSK9 inhibitors, ezetimibe, omega-3s, and emerging Lp(a)-targeted therapies in the pipeline — what your options are if you genuinely can&apos;t tolerate statins[32:06] — Why guidelines change — and why that&apos;s not the same as being lied to: the science evolves, the tools get better, and the recommendations follow[33:13] — Pandemic messaging lessons: Dr. Komal on &quot;flatten the curve,&quot; what it actually meant, and how the gap between what medicine knows and what gets communicated to the public continues to fuel mistrust[34:31] — Rebuilding trust in science: Dr. Komal&apos;s experience at her Washington hospital during the first COVID deaths in the country, the CDC arriving to learn rather than lead, and why uncertainty in medicine is not the same as deception[38:33] — Midlife women and heart risk: why cardiometabolic risk isn&apos;t discussed nearly enough in the context of menopause, and what Dr. Komal is doing in her own practice to screen every midlife woman proactively — before anything on the standard panel looks alarming[40:04] — Estrogen loss and metabolic shift: the mechanism behind why visceral fat increases, muscle mass drops, insulin resistance develops, and cholesterol climbs when estrogen declines — and why this is biology, not a lifestyle failure[41:09] — Inflammation markers and hsCRP: why both physicians check high-sensitivity CRP routinely, what Dr. Komal found when hers came back elevated despite well-controlled autoimmune disease, and the vicious cycle of visceral fat and cardiovascular inflammation[43:26] — Personal plans, statins, and GLP-1s: Dr. Tsui shares her own treatment journey — transdermal estrogen, a statin, and adding back a GLP-1/GIP combination — and how her LDL dropped back below 70 and her hsCRP normalized. The reminder that everyone&apos;s genetics are different, and so is the plan.[45:22] — Lifestyle first, medication timing: how Dr. Tsui structures the first conversation with patients — a deep dive on diet, body composition, schedule, and food access — and her three-month reassessment framework before deciding on pharmacologic intervention[47:47] — Calcium scores and hidden disease: the coronary artery calcium (CAC) score as a window into subclinical atherosclerosis — including Dr. Tsui&apos;s own score of 214 at age 43, discovered while trying to prove her heart was healthier than her husband&apos;s[50:12] — Statin side effects and PCSK9 inhibitors: managing myopathy, dosing strategies for women (who metabolize statins differently), and how Dr. Tsui gets about 75% of patients who need a PCSK9 inhibitor to actually commit to it[51:37] — Insurance barriers to care: prior authorization requirements for PCSK9 inhibitors, the specialist referral runaround, and what happens to patients when the system gets in the way of evidence-based treatment[52:31] — What to ask your doctor: specific language and specific tests — family history, the PREVENT ASCVD calculator, Lp(a), ApoB, fasting insulin, ferritin, GLP-1 conversations, and the &quot;skinny fat&quot; discussion that Southeast Asian patients in particular deserve to have[55:19] — Family history, kids, and screening: when to start checking cholesterol in children (as early as age two with significant family history), why puberty brings new risk considerations, and a message to primary care physicians and their own patients — including the data on female physician mortality that should make all of us pause[57:24] — Closing thanks and where to find Dr. Harpreet Tsui: Coronado Health in Henderson, NV | coronadohealthdpc.com | @drharpreet.tsui on Instagram and TikTok Resources Mentioned<ul><li>2026 ACC/AHA Dyslipidemia Guidelines</li><li>PREVENT ASCVD Risk Calculator (American Heart Association)</li><li>MASALA Trial (South Asian cardiovascular health research)</li><li>Coronado Health: <a href='http://coronadohealthdpc.com'>coronadohealthdpc.com</a></li><li>Clearly Hormonal Episode with Dr. Ambreen Mohamed (CT coronary angiogram and women&apos;s heart disease — coming soon)</li></ul> ConnectDr. Komal Patil-Sisodia Endocrinologist | Internist | Obesity Medicine | Menopause Society Certified Practitioner 📍 Eastside Menopause &amp; Metabolism — Kirkland, WA | eastsidemm.com 📱 Instagram &amp; TikTok: @drpatilsisodiaDr. Harpreet Tsui Internist | Obesity Medicine Specialist | Founder, Coronado Health 📍 Henderson, NV | coronadohealthdpc.com 📱 Instagram &amp; TikTok: @drharpreet.tsuiThanks for listening. Find more info about Clearly Hormonal on the <a href='https://eastsidemm.com/podcast'>website</a> or <a href='https://www.instagram.com/clearlyhormonal'>Instagram</a>.

<description>&lt;p&gt;&lt;a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new"&gt;📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;The number-one cause of death in women is still heart disease — and perimenopause is where your cardiovascular risk starts to quietly climb. This week, Dr. Komal sits down with Dr. Harpreet Tsui, an internist, obesity medicine specialist, and founder of Coronado Health (a direct primary care practice in Nevada), to break down the 2026 ACC/AHA Dyslipidemia Guidelines — the biggest update to cholesterol guidelines in years.&lt;/p&gt;&lt;p&gt;This is a personal episode. Both physicians are Southeast Asian women with significant family histories of heart disease. Both are managing their own cardiometabolic health in real time. And neither of them is willing to accept &amp;quot;your numbers look fine&amp;quot; as the end of the conversation.&lt;/p&gt;&lt;p&gt;They cover what&amp;apos;s changed in the guidelines, which genetic cholesterol markers your doctor may not be ordering, why perimenopause can flip your lipid panel overnight, and the exact language to use at your next appointment to get the full picture.&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;br/&gt;Guest&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Dr. Harpreet Tsui, MD&lt;/b&gt; Internist | Obesity Medicine Specialist | Founder, Coronado Health (Direct Primary Care, Henderson, NV)&lt;/p&gt;&lt;p&gt;📍 coronadohealthdpc.com 📱 Instagram &amp;amp; TikTok: @drharpreet.tsui&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;br/&gt;Timestamps&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;[0:00]&lt;/b&gt; — Podcast intro and medical disclaimer&lt;/p&gt;&lt;p&gt;&lt;b&gt;[1:03]&lt;/b&gt; — Meet Dr. Harpreet Tsui: internist, obesity medicine specialist, founder of Coronado Health in Nevada — and why both she and Dr. Komal wanted to have this conversation as Southeast Asian women with significant family histories of heart disease&lt;/p&gt;&lt;p&gt;&lt;b&gt;[2:48]&lt;/b&gt; — Why direct primary care: Dr. Tsui on leaving the 15-minute appointment model to build a practice centered on women&amp;apos;s health, obesity medicine, and actually having enough time to talk&lt;/p&gt;&lt;p&gt;&lt;b&gt;[4:42]&lt;/b&gt; — Guidelines confusion and statins: from the clear LDL targets of residency training to the ambiguous &amp;quot;lower it if you feel like it&amp;quot; era — and why statins have gotten an unfair reputation despite data showing they reduce heart disease, stroke risk, and even drive plaque regression&lt;/p&gt;&lt;p&gt;&lt;b&gt;[7:01]&lt;/b&gt; — Mistrust and culture around medications: immigrant family attitudes toward asking for help, the &amp;quot;I can do it on my own&amp;quot; mentality, and how even physicians absorb enough noise to hesitate — including Dr. Tsui, who prescribed herself a statin and left it on her nightstand for two weeks before she could take it&lt;/p&gt;&lt;p&gt;&lt;b&gt;[12:14]&lt;/b&gt; — Key update: risk-based treatment replaces number-chasing. The new PREVENT ASCVD calculator factors in HDL, triglycerides, family history, ethnicity, and even zip code — and gives you both a 10-year and 30-year cardiovascular risk estimate, not just a snapshot of today&lt;/p&gt;&lt;p&gt;&lt;b&gt;[16:11]&lt;/b&gt; — Perimenopause and lipid shifts: why cholesterol can change dramatically when estrogen drops, even when lifestyle hasn&amp;apos;t. Dr. Tsui&amp;apos;s LDL went from 77 to 177 in perimenopause. Dr. Komal&amp;apos;s Lp(a) was normal before — and then it wasn&amp;apos;t. Neither of them did anything differently.&lt;/p&gt;&lt;p&gt;&lt;b&gt;[20:59]&lt;/b&gt; — ApoB and Lp(a) explained: the two genetic cholesterol markers now in the 2026 guidelines as independent cardiac risk factors. Your standard lipid panel can look stone-cold normal while these are quietly elevated — and why both physicians now check them routinely on midlife women&lt;/p&gt;&lt;p&gt;&lt;b&gt;[23:28]&lt;/b&gt; — Female-specific risk factors are finally in the guidelines: menopause, PCOS, gestational diabetes, and preeclampsia are now formally recognized as independent cardiovascular risk factors. The gestational diabetes gap — including the postpartum glucose tolerance test that routinely gets missed — and why preeclampsia has lifelong cardiovascular implications&lt;/p&gt;&lt;p&gt;&lt;b&gt;[29:32]&lt;/b&gt; — Lower LDL targets and the case for being more aggressive: below 70 for high-risk patients, below 55 for very high-risk — and why vascular specialists have been pushing for LDL at or below 50 for years ahead of these guidelines&lt;/p&gt;&lt;p&gt;&lt;b&gt;[31:33]&lt;/b&gt; — Beyond statins: PCSK9 inhibitors, ezetimibe, omega-3s, and emerging Lp(a)-targeted therapies in the pipeline — what your options are if you genuinely can&amp;apos;t tolerate statins&lt;/p&gt;&lt;p&gt;&lt;b&gt;[32:06]&lt;/b&gt; — Why guidelines change — and why that&amp;apos;s not the same as being lied to: the science evolves, the tools get better, and the recommendations follow&lt;/p&gt;&lt;p&gt;&lt;b&gt;[33:13]&lt;/b&gt; — Pandemic messaging lessons: Dr. Komal on &amp;quot;flatten the curve,&amp;quot; what it actually meant, and how the gap between what medicine knows and what gets communicated to the public continues to fuel mistrust&lt;/p&gt;&lt;p&gt;&lt;b&gt;[34:31]&lt;/b&gt; — Rebuilding trust in science: Dr. Komal&amp;apos;s experience at her Washington hospital during the first COVID deaths in the country, the CDC arriving to learn rather than lead, and why uncertainty in medicine is not the same as deception&lt;/p&gt;&lt;p&gt;&lt;b&gt;[38:33]&lt;/b&gt; — Midlife women and heart risk: why cardiometabolic risk isn&amp;apos;t discussed nearly enough in the context of menopause, and what Dr. Komal is doing in her own practice to screen every midlife woman proactively — before anything on the standard panel looks alarming&lt;/p&gt;&lt;p&gt;&lt;b&gt;[40:04]&lt;/b&gt; — Estrogen loss and metabolic shift: the mechanism behind why visceral fat increases, muscle mass drops, insulin resistance develops, and cholesterol climbs when estrogen declines — and why this is biology, not a lifestyle failure&lt;/p&gt;&lt;p&gt;&lt;b&gt;[41:09]&lt;/b&gt; — Inflammation markers and hsCRP: why both physicians check high-sensitivity CRP routinely, what Dr. Komal found when hers came back elevated despite well-controlled autoimmune disease, and the vicious cycle of visceral fat and cardiovascular inflammation&lt;/p&gt;&lt;p&gt;&lt;b&gt;[43:26]&lt;/b&gt; — Personal plans, statins, and GLP-1s: Dr. Tsui shares her own treatment journey — transdermal estrogen, a statin, and adding back a GLP-1/GIP combination — and how her LDL dropped back below 70 and her hsCRP normalized. The reminder that everyone&amp;apos;s genetics are different, and so is the plan.&lt;/p&gt;&lt;p&gt;&lt;b&gt;[45:22]&lt;/b&gt; — Lifestyle first, medication timing: how Dr. Tsui structures the first conversation with patients — a deep dive on diet, body composition, schedule, and food access — and her three-month reassessment framework before deciding on pharmacologic intervention&lt;/p&gt;&lt;p&gt;&lt;b&gt;[47:47]&lt;/b&gt; — Calcium scores and hidden disease: the coronary artery calcium (CAC) score as a window into subclinical atherosclerosis — including Dr. Tsui&amp;apos;s own score of 214 at age 43, discovered while trying to prove her heart was healthier than her husband&amp;apos;s&lt;/p&gt;&lt;p&gt;&lt;b&gt;[50:12]&lt;/b&gt; — Statin side effects and PCSK9 inhibitors: managing myopathy, dosing strategies for women (who metabolize statins differently), and how Dr. Tsui gets about 75% of patients who need a PCSK9 inhibitor to actually commit to it&lt;/p&gt;&lt;p&gt;&lt;b&gt;[51:37]&lt;/b&gt; — Insurance barriers to care: prior authorization requirements for PCSK9 inhibitors, the specialist referral runaround, and what happens to patients when the system gets in the way of evidence-based treatment&lt;/p&gt;&lt;p&gt;&lt;b&gt;[52:31]&lt;/b&gt; — What to ask your doctor: specific language and specific tests — family history, the PREVENT ASCVD calculator, Lp(a), ApoB, fasting insulin, ferritin, GLP-1 conversations, and the &amp;quot;skinny fat&amp;quot; discussion that Southeast Asian patients in particular deserve to have&lt;/p&gt;&lt;p&gt;&lt;b&gt;[55:19]&lt;/b&gt; — Family history, kids, and screening: when to start checking cholesterol in children (as early as age two with significant family history), why puberty brings new risk considerations, and a message to primary care physicians and their own patients — including the data on female physician mortality that should make all of us pause&lt;/p&gt;&lt;p&gt;&lt;b&gt;[57:24]&lt;/b&gt; — Closing thanks and where to find Dr. Harpreet Tsui: Coronado Health in Henderson, NV | coronadohealthdpc.com | @drharpreet.tsui on Instagram and TikTok&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;br/&gt;Resources Mentioned&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;2026 ACC/AHA Dyslipidemia Guidelines&lt;/li&gt;&lt;li&gt;PREVENT ASCVD Risk Calculator (American Heart Association)&lt;/li&gt;&lt;li&gt;MASALA Trial (South Asian cardiovascular health research)&lt;/li&gt;&lt;li&gt;Coronado Health: &lt;a href='http://coronadohealthdpc.com'&gt;coronadohealthdpc.com&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Clearly Hormonal Episode with Dr. Ambreen Mohamed (CT coronary angiogram and women&amp;apos;s heart disease — coming soon)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;&lt;br/&gt;Connect&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Dr. Komal Patil-Sisodia&lt;/b&gt; Endocrinologist | Internist | Obesity Medicine | Menopause Society Certified Practitioner 📍 Eastside Menopause &amp;amp; Metabolism — Kirkland, WA | eastsidemm.com 📱 Instagram &amp;amp; TikTok: @drpatilsisodia&lt;/p&gt;&lt;p&gt;&lt;b&gt;Dr. Harpreet Tsui&lt;/b&gt; Internist | Obesity Medicine Specialist | Founder, Coronado Health 📍 Henderson, NV | coronadohealthdpc.com 📱 Instagram &amp;amp; TikTok: @drharpreet.tsui&lt;/p&gt;&lt;p&gt;Thanks for listening. Find more info about Clearly Hormonal on the &lt;a href='https://eastsidemm.com/podcast'&gt;website&lt;/a&gt; or &lt;a href='https://www.instagram.com/clearlyhormonal'&gt;Instagram&lt;/a&gt;.&lt;/p&gt;</description>

📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply.  Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. The number-one cause of death in women is still heart disease — and perimenopause is where your cardiovascular risk starts to quietly climb. This week, Dr. Komal sits down with Dr. Harpreet Tsui, an internist, obesity medicine specialist, and founder of Coronado Health (...

Decoding the Risk: What New Cholesterol Guidelines Mean for Women with Dr. Harpreet Tsui

<a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new">📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.</a>Heart disease has long been framed as a “man’s disease” – but women are being missed, misdiagnosed, and overlooked in ways that can be life-threatening, especially within South Asian communities where cardiovascular risk often develops earlier and more aggressively. In this episode, Dr. Komal Patil-Sisodia sits down with advanced imaging and preventative cardiologist, Dr. Ambreen Mohamed, to unpack the evolving science of women’s cardiovascular health, the hormonal shifts that impact risk throughout midlife, and why prevention needs to start far earlier than most people realize. Together, they explore the subtle symptoms women experience that are too often dismissed, the intersection of menopause, PCOS, pregnancy complications, insulin resistance, and heart disease, and why traditional risk calculators frequently fail to capture the realities of South Asian patients. Most importantly, this conversation reframes prevention not as fear-based medicine, but as empowerment: understanding your risk factors early enough to change the trajectory of your health before disease develops. Connect with Dr. Mohamed: <a href='https://www.linkedin.com/in/ambreen-mohamed-md-facc-abb1b680/'>LinkedIn </a><a href='https://www.tiktok.com/@ambreenmmd'>TikTok </a><a href='http://www.instagram.com/drambreehmohamed'>Instagram </a><a href='https://ambreenmohamed.com/'>Website</a>Connect with me: <a href='https://www.linkedin.com/in/komal-patil-sisodia-md-2362097/'>LinkedIn </a><a href='https://www.tiktok.com/@drpatilsisodia'>TikTok </a><a href='https://www.instagram.com/drambreenmohamed'>Instagram</a><a href='https://eastsidemm.com'>Eastside Menopause &amp; Metabolism </a> Audio Stamps : 00:00 – Dr. Komal introduces Dr. Ambreen Mohamed and sets up the conversation around women’s cardiovascular health, prevention, and South Asian risk 00:00 Podcast Mission Setup01:05 Meet Dr Ambreen Mohamed04:38 Why Women Get Missed07:10 Women’s Heart Attack Symptoms11:18 Hormones Menopause PCOS Risk15:06 Pregnancy As Stress Test18:36 Menopause Hormone Therapy Debate25:59 South Asian Heart Risk Factors28:02 Advanced Lipids Lp(a) ApoB33:07 MASALA Study And Risk Tools36:27 Perimenopause Lp(a) Spike37:18 Estrogen and Lp(a) Research38:11 Who Counts as High Risk39:55 Doctors Still Learning42:12 Labs to Ask For43:31 Insulin Resistance Markers46:15 Beyond Labs and Blood Pressure47:52 Sleep Apnea and Heart Risk48:41 CAC Score When It Helps50:12 CT Angiogram and AI54:32 Lifestyle Changes to Start Now58:48 Advocating at the Doctor01:02:31 Wrap Up and Where to Find Her01:04:25 Final Takeaways and Call to ActionThanks for listening. Find more info about Clearly Hormonal on the <a href='https://eastsidemm.com/podcast'>website</a> or <a href='https://www.instagram.com/clearlyhormonal'>Instagram</a>.

<description>&lt;p&gt;&lt;a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new"&gt;📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Heart disease has long been framed as a “man’s disease” – but women are being missed, misdiagnosed, and overlooked in ways that can be life-threatening, especially within South Asian communities where cardiovascular risk often develops earlier and more aggressively.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;In this episode, Dr. Komal Patil-Sisodia sits down with advanced imaging and preventative cardiologist, Dr. Ambreen Mohamed, to unpack the evolving science of women’s cardiovascular health, the hormonal shifts that impact risk throughout midlife, and why prevention needs to start far earlier than most people realize.&lt;br/&gt;Together, they explore the subtle symptoms women experience that are too often dismissed, the intersection of menopause, PCOS, pregnancy complications, insulin resistance, and heart disease, and why traditional risk calculators frequently fail to capture the realities of South Asian patients. Most importantly, this conversation reframes prevention not as fear-based medicine, but as empowerment: understanding your risk factors early enough to change the trajectory of your health before disease develops.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;b&gt;&lt;em&gt;Connect with Dr. Mohamed: &lt;/em&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://www.linkedin.com/in/ambreen-mohamed-md-facc-abb1b680/'&gt;&lt;b&gt;LinkedIn&lt;br/&gt;&lt;/b&gt;&lt;/a&gt;&lt;a href='https://www.tiktok.com/@ambreenmmd'&gt;&lt;b&gt;TikTok&lt;br/&gt;&lt;/b&gt;&lt;/a&gt;&lt;a href='http://www.instagram.com/drambreehmohamed'&gt;&lt;b&gt;Instagram&lt;br/&gt;&lt;/b&gt;&lt;/a&gt;&lt;a href='https://ambreenmohamed.com/'&gt;&lt;b&gt;Website&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;em&gt;Connect with me: &lt;/em&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://www.linkedin.com/in/komal-patil-sisodia-md-2362097/'&gt;&lt;b&gt;LinkedIn&lt;br/&gt;&lt;/b&gt;&lt;/a&gt;&lt;a href='https://www.tiktok.com/@drpatilsisodia'&gt;&lt;b&gt;TikTok &lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://www.instagram.com/drambreenmohamed'&gt;&lt;b&gt;Instagram&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://eastsidemm.com'&gt;&lt;b&gt;Eastside Menopause &amp;amp; Metabolism &lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Audio Stamps :&lt;/b&gt;&lt;br/&gt;00:00 – Dr. Komal introduces Dr. Ambreen Mohamed and sets up the conversation around women’s cardiovascular health, prevention, and South Asian risk&lt;/p&gt;&lt;p&gt;&lt;br/&gt;00:00 Podcast Mission Setup&lt;/p&gt;&lt;p&gt;01:05 Meet Dr Ambreen Mohamed&lt;/p&gt;&lt;p&gt;04:38 Why Women Get Missed&lt;/p&gt;&lt;p&gt;07:10 Women’s Heart Attack Symptoms&lt;/p&gt;&lt;p&gt;11:18 Hormones Menopause PCOS Risk&lt;/p&gt;&lt;p&gt;15:06 Pregnancy As Stress Test&lt;/p&gt;&lt;p&gt;18:36 Menopause Hormone Therapy Debate&lt;/p&gt;&lt;p&gt;25:59 South Asian Heart Risk Factors&lt;/p&gt;&lt;p&gt;28:02 Advanced Lipids Lp(a) ApoB&lt;/p&gt;&lt;p&gt;33:07 MASALA Study And Risk Tools&lt;/p&gt;&lt;p&gt;36:27 Perimenopause Lp(a) Spike&lt;/p&gt;&lt;p&gt;37:18 Estrogen and Lp(a) Research&lt;/p&gt;&lt;p&gt;38:11 Who Counts as High Risk&lt;/p&gt;&lt;p&gt;39:55 Doctors Still Learning&lt;/p&gt;&lt;p&gt;42:12 Labs to Ask For&lt;/p&gt;&lt;p&gt;43:31 Insulin Resistance Markers&lt;/p&gt;&lt;p&gt;46:15 Beyond Labs and Blood Pressure&lt;/p&gt;&lt;p&gt;47:52 Sleep Apnea and Heart Risk&lt;/p&gt;&lt;p&gt;48:41 CAC Score When It Helps&lt;/p&gt;&lt;p&gt;50:12 CT Angiogram and AI&lt;/p&gt;&lt;p&gt;54:32 Lifestyle Changes to Start Now&lt;/p&gt;&lt;p&gt;58:48 Advocating at the Doctor&lt;/p&gt;&lt;p&gt;01:02:31 Wrap Up and Where to Find Her&lt;/p&gt;&lt;p&gt;01:04:25 Final Takeaways and Call to Action&lt;/p&gt;&lt;p&gt;Thanks for listening. Find more info about Clearly Hormonal on the &lt;a href='https://eastsidemm.com/podcast'&gt;website&lt;/a&gt; or &lt;a href='https://www.instagram.com/clearlyhormonal'&gt;Instagram&lt;/a&gt;.&lt;/p&gt;</description>

📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply.  Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Heart disease has long been framed as a “man’s disease” – but women are being missed, misdiagnosed, and overlooked in ways that can be life-threatening, especially within South Asian communities where cardiovascular risk often develops earlier and more aggressively.  In ...

Why Women’s Heart Disease Gets Missed with Dr. Ambreen Mohamed

<a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new">📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.</a>Between trackers, lab tests, supplements, hormone experts, social media, and podcasts, women have more access to health information than ever before. However, despite (and sometimes because) of these resources, many women end up feeling confused and distrustful of their own bodies. In this episode, Dr. Komal Patil-Sisodia explores various factors contributing to the ambiguity, including long-standing systemic gaps in women’s healthcare. From “normal” lab results that don’t align with very real symptoms to a healthcare system built around specialties instead of whole-body care, women have been conditioned to push through pain and discomfort in order to adjust to everyone’s convenience but their own.If you’ve struggled to find clear, conclusive answers about your health, this episode highlights why self-advocacy is essential in securing the individual care and comprehensive treatment you deserve. Connect with me: <a href='https://www.tiktok.com/@drpatilsisodia'>TikTok </a><a href='https://www.instagram.com/drpatilsisodia/'>Instagram</a><a href='https://eastsidemm.com/'>Eastside Menopause &amp; Metabolism</a> Audio Stamps :01:06 – Why “normal” labs can often feel more devastating than reassuring 03:35 – Why better access to women’s health information hasn’t created more clarity 05:51 – Problem #1: How fragmented medical specialties leave women trying to piece together their own health story09:23 – Problem #2: What “normal” lab results actually mean and why population-based reference ranges can miss meaningful hormonal and metabolic shifts14:21 – Problem #3: How the “push through” culture discourages women from trusting themselves and engaging in self-advocacy17:07 – Problem #4: Why the lack of understanding around the whole-body impact of hormones contributes to the general confusion  20:40 – Problem #5: How the missing roadmap for midlife women’s health adversely impacts access to individualized care and effective treatment options27:32 – How the ambiguity in women’s health is due to systemic weaknesses rather than personal onesThanks for listening. Find more info about Clearly Hormonal on the <a href='https://eastsidemm.com/podcast'>website</a> or <a href='https://www.instagram.com/clearlyhormonal'>Instagram</a>.

<description>&lt;p&gt;&lt;a target="_blank" href="https://www.buzzsprout.com/2301529/fan_mail/new"&gt;📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Between trackers, lab tests, supplements, hormone experts, social media, and podcasts, women have more access to health information than ever before. However, despite (and sometimes &lt;em&gt;because&lt;/em&gt;) of these resources, many women end up feeling confused and distrustful of their own bodies. &lt;/p&gt;&lt;p&gt;In this episode, Dr. Komal Patil-Sisodia explores various factors contributing to the ambiguity, including long-standing systemic gaps in women’s healthcare. From “normal” lab results that don’t align with very real symptoms to a healthcare system built around specialties instead of whole-body care, women have been conditioned to push through pain and discomfort in order to adjust to everyone’s convenience but their own.&lt;/p&gt;&lt;p&gt;If you’ve struggled to find clear, conclusive answers about your health, this episode highlights why self-advocacy is essential in securing the individual care and comprehensive treatment you deserve.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;em&gt;Connect with me: &lt;/em&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://www.tiktok.com/@drpatilsisodia'&gt;TikTok &lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://www.instagram.com/drpatilsisodia/'&gt;Instagram&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href='https://eastsidemm.com/'&gt;Eastside Menopause &amp;amp; Metabolism&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;&lt;em&gt;Audio Stamps :&lt;/em&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;01:06 – Why “normal” labs can often feel more devastating than reassuring &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;03:35 – Why better access to women’s health information hasn’t created more clarity &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;05:51 – Problem #1: How fragmented medical specialties leave women trying to piece together their own health story&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;09:23 – Problem #2: What “normal” lab results actually mean and why population-based reference ranges can miss meaningful hormonal and metabolic shifts&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;14:21 – Problem #3: How the “push through” culture discourages women from trusting themselves and engaging in self-advocacy&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;17:07 – Problem #4: Why the lack of understanding around the whole-body impact of hormones contributes to the general confusion  &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;20:40 – Problem #5: How the missing roadmap for midlife women’s health adversely impacts access to individualized care and effective treatment options&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;27:32 – How the ambiguity in women’s health is due to systemic weaknesses rather than personal ones&lt;/em&gt;&lt;/p&gt;&lt;p&gt;Thanks for listening. Find more info about Clearly Hormonal on the &lt;a href='https://eastsidemm.com/podcast'&gt;website&lt;/a&gt; or &lt;a href='https://www.instagram.com/clearlyhormonal'&gt;Instagram&lt;/a&gt;.&lt;/p&gt;</description>

📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply.  Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Between trackers, lab tests, supplements, hormone experts, social media, and podcasts, women have more access to health information than ever before. However, despite (and sometimes because) of these resources, many women end up feeling confused and distrustful of their ...

Dismissed & Confused: Why Women Stop Trusting Their Bodies

Have you ever wondered why your body feels like it's falling apart just as you're hitting your stride in other areas of your life? Join Dr. Komal Patil-Sisodia as she explores women’s metabolic health changes that start in perimenopause. The episodes center around educating and empowering women to have open dialogue with their doctors so that they can achieve their best metabolic health. Dr. Patil-Sisodia is board certified in Endocrinology,&nbsp; Obesity Medicine and Internal Medicine. She is also a Menopause Society Certified Practitioner. Any medical discussion on this podcast is purely for educational purposes and is not individualized medical advice. Please consult with your doctor to discuss any health concerns you may have.

Clearly Hormonal

Details

Recent Episodes